Cutting Edge Conversations: Discovering New Innovations in Oncology
Join experts, including Aptamer Group CTO, Dr David Bunka, for a conversation on recent progress in cancer research, including novel treatments, experimental therapies, and drug development.
Dr David Bunka discusses how Optimer technology is enabling new strategies in cancer treatment, including the targeted delivery of diverse payloads to cancer cells for precision chemotherapy, or gene therapy approaches.
This was a great session where we collaborated with Kromatid and BioIVT to discuss the latest developments in the field.
Aptamer Group presentation begins at 08:41 and the Q&A is at 44:48.
